Live
Home·Deals·biopharmaceutical·ABS acquires Cureline
SEO URLwww.firestrike.ai/deals/cureline-abs-acquisition-2026-1
acquisitionAnnounced · Jan 7, 2026biopharmaceuticalSource · CredibleArticle · Factual
Cureline
ABS
Cureline · ABS

ABS acquires Cureline

David Najork
David Najork · Founding Software Engineer
Published · Updated · 1 min read
ShareXLinkedInEmail
Deal value
Target
Cureline
Cureline
South San Francisco, California
Acquirer
ABS
ABS
Full Acquisition
Status
Announced

ABS agreed to acquire Cureline. Reported deal value: Undisclosed. Status: Announced. Sector: biopharmaceutical. Target headquarters context: South San Francisco, California, United States.

This page summarizes publicly available information about the transaction as of 2026-01-07. Figures and status may change as filings and press coverage update.

January 6,2026 — ABS Bio , Inc. , a leader in biospecimen sourcing, cellculture services and biorepository solutions for the global pharmaceutical andbiotechnology industry, today announced the acquisition of Cureline , Inc. , aSouth San Francisco , California -based provider of specimen procurement andhistology services

Deal timeline

Announced
Jan 7, 2026 · biospace.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in biopharmaceutical. Figures and status may change as sources update.

Sources: biospace.com · Primary article · FireStrike proprietary index